Phuturdex › Diseases › Infratentorial neoplasm
Drugs in development · updated 30 October 2026
Infratentorial neoplasm: drugs in development
As of 30 October 2026 there are 2 active clinical trials (recruiting or ongoing, phases I–III) on 8 drugs for infratentorial neoplasm. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| BupivacaineExparel, Bupivacain | III | 1 | NCT07878156 |
| DexmedetomidineIgalmi®, Precedex® | III | 1 | NCT07878156 |
| CisplatinCis Platinum, Cisplatine | II | 1 | NCT01878617 |
| CyclophosphamideCyclophosphamid, Cytoxan | II | 1 | NCT01878617 |
| GemcitabineGemcitabin, Gemzar | II | 1 | NCT01878617 |
| PemetrexedAxtle®, Pemfexy® | II | 1 | NCT01878617 |
| VincristineVincristin, Oncovin [vincristine] | II | 1 | NCT01878617 |
| VismodegibErivedge® | II | 1 | NCT01878617 |
Sorted by most advanced phase and number of active trials.
All 8 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Diffuse Intrinsic Pontine Glioma 40 drugs
- Glioma 184 drugs
- Brain Neoplasms 190 drugs
- Glioblastoma 245 drugs
- Medulloblastoma 77 drugs
- Astrocytoma 64 drugs
- Ependymoma 56 drugs
- Rhabdoid tumor 52 drugs
- Central nervous system neoplasm 70 drugs
- Gliosarcoma 34 drugs
- Oligodendroglioma 26 drugs
- Osteosarcoma 101 drugs
Broader categories
- Neoplasm 671 drugs
- Brain Diseases 23 drugs
- Central nervous system disease 38 drugs
- Nervous System Diseases 39 drugs
- Central nervous system neoplasm 70 drugs
- Nervous system neoplasm 4 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D015192 “Infratentorial Neoplasms”.